Form 4: CEL-SCI Corp Executive Eyal Talor Acquires Additional Shares
SEC Form 4
Eyal Talor, Chief Scientific Officer of CEL-SCI Corp, reports the acquisition of 1,256 shares of common stock at a price of $1.91 per share.
Summary
- On March 29, 2024, Eyal Talor, the Chief Scientific Officer of CEL-SCI Corp, acquired 1,256 shares of common stock.
- The shares were purchased at a price of $1.91 per share.
- Following the transaction, Talor directly owns 114,264 shares of CEL-SCI Corp.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects a routine transaction by an executive, which could be interpreted as a positive sign of confidence, but without further context, it's difficult to gauge the overall impact.
Positives
- The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider trading activity is closely monitored by regulators and investors as it can provide insights into the company's performance and future prospects. Form 4 filings are a routine part of this monitoring process.
Stakeholder Impact
- The acquisition of shares by a company executive may have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Date of transaction: Eyal Talor acquired 1,256 shares of common stock. |
| 04/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.